CD163 and neoplasm: hrHPV+ tumors had markedly higher numbers of CD14+, CD68+ and CD163+ myeloid cells in the intratumoral tumor (IT Tumor) compartment compared to hrHPV− tumors (p=0.001, p < 0.001, p=0.002, respectively).